GlaxoSmithKline (GSK) Misses Q2 EPS by 71c

GlaxoSmithKline (NYSE: GSK) reported Q2 EPS of GBP0.47, GBP0.71 worse than the analyst estimate of GBP1.18. Revenue for the quarter came in at GBP7.99 billion versus the consensus estimate of GBP10.58 billion.

For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Koninklijke Ahold Delhaize NV (AD:NA) (ADRNY) Placed on Negative Catalyst Watch at JPMorgan
• RBC Capital Starts PRO REIT (PRV-U:CN) at Outperform